psiXchange enables SUSARs and other safety documents to be sent in from any external system and then automatically dispatched out to sites and ECs, together with full tracking and a detailed audit trail.
psiXchange connects with existing data sources - including Oracle Argus, ArisGlobal, IMPACT, Siebel Clinical and Veeva Vault - and accepts documents in any format (such as XML, PDF, XLS).
psiXchange empowers organisations to overcome traditional manual obstacles, and to track progress in real time. As a result, your team will be able to proactively manage receipt acknowledgements and oversee distribution from a user-friendly dashboard.
Suspected unexpected serious adverse reactions (SUSARs) - reports of incidents that occur during a clinical study - must be distributed to national competent authorities and a number of other recipient groups, such as Ethic Committees or Institutional Review Boards, in addition to investigators participating in the respective studies.